| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0002-2377-11 | 0002-2377 | HUMAN PRESCRIPTION DRUG | EMGALITY | galcanezumab-gnlm | INJECTION, SOLUTION | SUBCUTANEOUS | 20190118 | N/A | BLA | BLA761063 | Eli Lilly and Company | GALCANEZUMAB | 120 mg/mL | 1 SYRINGE in 1 CARTON (0002-2377-11) / 1 mL in 1 SYRINGE (0002-2377-01) |
| 0002-3115-09 | 0002-3115 | HUMAN PRESCRIPTION DRUG | EMGALITY | galcanezumab-gnlm | INJECTION, SOLUTION | SUBCUTANEOUS | 20190617 | N/A | BLA | BLA761063 | Eli Lilly and Company | GALCANEZUMAB | 100 mg/mL | 3 SYRINGE in 1 CARTON (0002-3115-09) / 1 mL in 1 SYRINGE (0002-3115-01) |
| 0002-1436-11 | 0002-1436 | HUMAN PRESCRIPTION DRUG | EMGALITY | galcanezumab-gnlm | INJECTION, SOLUTION | SUBCUTANEOUS | 20180927 | N/A | BLA | BLA761063 | Eli Lilly and Company | GALCANEZUMAB | 120 mg/mL | 1 SYRINGE in 1 CARTON (0002-1436-11) / 1 mL in 1 SYRINGE (0002-1436-01) |
| 0002-1436-61 | 0002-1436 | HUMAN PRESCRIPTION DRUG | EMGALITY | galcanezumab-gnlm | INJECTION, SOLUTION | SUBCUTANEOUS | 20180927 | N/A | BLA | BLA761063 | Eli Lilly and Company | GALCANEZUMAB | 120 mg/mL | 2 SYRINGE in 1 CARTON (0002-1436-61) / 1 mL in 1 SYRINGE |